Literature DB >> 12529095

Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system.

Mark A Crowther1, John G Kelton.   

Abstract

Congenital causes of venous thrombosis have gained increasing prominence with the description of the factor V Leiden mutation and the prothrombin gene mutation. More recently, the description of the association between increased levels of coagulation factors and venous thrombosis and the finding that patients with thrombophilia can harbor more than one prothrombotic state have further increased the clinical relevance of the congenital thrombophilic states. In this qualitative review, we summarize current knowledge of the congenital prothrombotic states and propose a simple classification system that divides the states into two broad groups: those associated with reduced levels of the inhibitors of the coagulation cascade and those associated with increased levels or function of the coagulation factors. The first group is less common than the second, but it is associated with a much higher risk for venous thrombosis. This review provides clinicians with an evidence-based, practical guide to the congenital prothrombotic states.

Entities:  

Mesh:

Year:  2003        PMID: 12529095     DOI: 10.7326/0003-4819-138-2-200301210-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 2.  Venous thromboembolism.

Authors:  Andrew D Blann; Gregory Y H Lip
Journal:  BMJ       Date:  2006-01-28

Review 3.  Haematology and neurology.

Authors:  Steven Austin; Hannah Cohen; Nick Losseff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

4.  Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Andrea Cervi; James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2019-04-01       Impact factor: 3.397

5.  Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for factor V Leiden.

Authors:  Tracy Manuck; D Ware Branch; Yinglei Lai; Baha Sibai; Catherine Y Spong; George Wendel; Katharine Wenstrom; Philip Samuels; Steve N Caritis; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  J Reprod Immunol       Date:  2010-05-02       Impact factor: 4.054

6.  Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism.

Authors:  Deborah A Lewis; Sunil Suchindran; Michele G Beckman; W Craig Hooper; Althea M Grant; John A Heit; Marilyn Manco-Johnson; Stephan Moll; Claire S Philipp; Kristy Kenney; Christine De Staercke; Meredith E Pyle; Jen-Tsan Chi; Thomas L Ortel
Journal:  Thromb Res       Date:  2015-02-07       Impact factor: 3.944

7.  A natural language processing algorithm to define a venous thromboembolism phenotype.

Authors:  Eugenia R McPeek Hinz; Lisa Bastarache; Joshua C Denny
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

8.  Factor V Leiden mutation is not a predisposing factor for acute coronary syndromes.

Authors:  G Himabindu; D Rajasekhar; K Latheef; P V G K Sarma; V Vanajakshamma; Abhijit Chaudhury; Aparna R Bitla
Journal:  Indian Heart J       Date:  2012-07-27

Review 9.  Etiology and consequences of thrombosis in abdominal vessels.

Authors:  Yusuf Bayraktar; Ozgur Harmanci
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

10.  Normal levels of protein C and protein S tested in the acute phase of a venous thromboembolic event are not falsely elevated.

Authors:  Leonard Minuk; Alejandro Lazo-Langner; Judy Kovacs; Melinda Robbins; Bev Morrow; Michael Kovacs
Journal:  Thromb J       Date:  2010-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.